The University of Manchester has formed a joint venture with Morningside to carry out clinical trials of various digital health technologies developed by the investment group's portfolio co
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
